Wang, X.; Kaiser, H.; Kvist-Hansen, A.; McCauley, B.D.; Skov, L.; Hansen, P.R.; Becker, C.
IL-17 Pathway Members as Potential Biomarkers of Effective Systemic Treatment and Cardiovascular Disease in Patients with Moderate-to-Severe Psoriasis. Int. J. Mol. Sci. 2022, 23, 555.
https://doi.org/10.3390/ijms23010555
AMA Style
Wang X, Kaiser H, Kvist-Hansen A, McCauley BD, Skov L, Hansen PR, Becker C.
IL-17 Pathway Members as Potential Biomarkers of Effective Systemic Treatment and Cardiovascular Disease in Patients with Moderate-to-Severe Psoriasis. International Journal of Molecular Sciences. 2022; 23(1):555.
https://doi.org/10.3390/ijms23010555
Chicago/Turabian Style
Wang, Xing, Hannah Kaiser, Amanda Kvist-Hansen, Benjamin D. McCauley, Lone Skov, Peter Riis Hansen, and Christine Becker.
2022. "IL-17 Pathway Members as Potential Biomarkers of Effective Systemic Treatment and Cardiovascular Disease in Patients with Moderate-to-Severe Psoriasis" International Journal of Molecular Sciences 23, no. 1: 555.
https://doi.org/10.3390/ijms23010555
APA Style
Wang, X., Kaiser, H., Kvist-Hansen, A., McCauley, B. D., Skov, L., Hansen, P. R., & Becker, C.
(2022). IL-17 Pathway Members as Potential Biomarkers of Effective Systemic Treatment and Cardiovascular Disease in Patients with Moderate-to-Severe Psoriasis. International Journal of Molecular Sciences, 23(1), 555.
https://doi.org/10.3390/ijms23010555